Journals / Türk Biyokimya Dergisi / 2019 / Cilt: 44 - Sayı: 4

Investigation of tyrosinase inhibition by some 1,2,4 triazole derivative compounds: in vitro and in silico mechanisms

Bazı 1,2,4 triazol türevi bileşiklerin in vitro ve in siliko mekanizmalarla tirozinaz inhibisyonunun incelenmesi

Pages
473–481
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Tyrosinase inhibition type and Ki value were found to be uncompetitive and 370.7  0.3 M, respec- tively, in the presence of B9 compound.Conclusion: These results suggest that B9 compound is a potential tyrosinase inhibitor.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Tyrosinase plays a central role in the bio- synthesis pathway of melanin pigment.
📊
Key Findings & Data:Therefore, determination of inhibitor molecules for tyrosinase has a promising potential for therapies of some diseases and is an alternative method for keeping insects under control.Material and methods: In this study, 1-hepthyl-3-(4- methoxybenzyl)-4H-1,2,4-triazole-5-one derivative (A6, A8, A15) and 3-(4-chlorophenyl)- 5-(4-methoxybenzyl)-4H-1,2,4- triazole (B5, B9, B13) derivative compounds were evaluated in terms of their potential for mushroom tyrosinase inhibi- tion.
💡
Conclusion & Impact:Tyrosinase inhibition type and Ki value were found to be uncompetitive and 370.7  0.3 M, respec- tively, in the presence of B9 compound.Conclusion: These results suggest that B9 compound is a potential tyrosinase inhibitor.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background: Tyrosinase plays a central role in the bio- synthesis pathway of melanin pigment. Melanin protects human skin against radiation and its unusual levels cause some skin disorders such as pregnancy scar, oldness spots and melanoma. Tyrosinase has also been linked to Parkin- son’s and other neurodegenerative diseases. In addition, melanin plays a critical role as a defense molecule for insects during wound healing and is important for their life. Therefore, determination of inhibitor molecules for tyrosinase has a promising potential for therapies of some diseases and is an alternative method for keeping insects under control.Material and methods: In this study, 1-hepthyl-3-(4- methoxybenzyl)-4H-1,2,4-triazole-5-one derivative (A6, A8, A15) and 3-(4-chlorophenyl)- 5-(4-methoxybenzyl)-4H-1,2,4- triazole (B5, B9, B13) derivative compounds were evaluated in terms of their potential for mushroom tyrosinase inhibi- tion. IC50 values of these six molecules were determined.Results: It was seen that B9 molecule was the most effec- tive inhibitor. Docking studies also nearly supported this end result. Tyrosinase inhibition type and Ki value were found to be uncompetitive and 370.7  0.3 M, respec- tively, in the presence of B9 compound.Conclusion: These results suggest that B9 compound is a potential tyrosinase inhibitor.

Özet

Amaç: Tirozinaz, melanin pigmentinin biyosentez yolunda merkezi bir rol oynar. Melanin insan cildini rad- yasyona karşı korur ve artan miktarı hamilelik ve yaşlılık lekeleri ile melanoma gibi bazı cilt bozukluklarına neden olur. Tirozinaz ayrıca Parkinson ve diğer nörodejeneratif hastalıklarla da bağlantılıdır. Buna ek olarak, melanin böcekler için, yara iyileşmesi sırasında bir savunma molekülü olarak kritik bir rol oynar ve onların yaşamları için önemlidir. Bu nedenle, tirozinaz için inhibitör mole- küllerin belirlenmesi, bazı hastalıkların tedavileri için ümit verici bir potansiyele sahiptir ve böceklerin kontrol altında tutulmasi için alternatif bir yöntemdir. Gereç ve Yöntem: Bu çalışmada, 1-heptil-3-(4-metoksiben- zil)-4H-1,2,4-triazol-5-on türevi (A6, A8, A15) ve 3-(4-klo- rofenil)-5-(4-metoksibenzil)-4H-1,2,4-triazol (B5, B9, B13) türevi bileşikler, mantar tirozinaz inhibisyonu açısından potansiyel olarak değerlendirildi ve bu altı molekülün IC50 değerleri belirlendi. Bulgular: Çalışma sonucunda B9 molekülünün en etkili inhibitör olduğu görülmüştür. Doking çalışmaları da bu sonucu desteklemektedir. Tirozinaz inhibisyon tipinin ve Ki değerinin, B9 bileşiğinin varlığında sırasıyla unkompe- tetif ve 370.7  0.3 M olduğu bulundu. Sonuç: Bu sonuçlar, B9 bileşiğinin potansiyel bir tirozinaz inhibitörü olduğunu göstermektedir.

🔖

Cite This Article

AKATIN, M. Y., DEMİR, E. A., BEKİRCAN, O., ÇOLAK, A., YAŞAR, A. (2022). Investigation of tyrosinase inhibition by some 1,2,4 triazole derivative compounds: in vitro and in silico mechanisms. Türk Biyokimya Dergisi, Cilt: 44 - Sayı: 4, 473–481. https://ajindex.com/articles/620908

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Copeland RA. Evaluation of enzyme inhibitors in drug discovery. New Jersey: A John Wiley & Sons, Inc. Publication, 2005
  2. Ghani U, Ullah N. New potent inhibitors of tyrosinase: novel clues to binding of 1,3,4-thiadizole-2 (3H)-thiones, 1,3,4-oxadiazole-2 (3H)-thiones, 4–amino-1,2,4-triazole-5(4H)-thiones, and substi- tuted hydrazides to the dicopper active site. Bioorg Med Chem 2010;18:4042–8
  3. Ismaya WT, Rozeboom HJ, Weijn A, Mes JJ, Fusetti F, Wichers HJ, et al. Crystal structure of Agaricus bisporus mushroom tyrosi- nase: identity of the tetramer subunits and interaction with tropolone. Biochemistry 2011;50:5477–86
  4. Ando H, Kondoh H, Ichihashi M, Hearing VJ. Approaches to iden- tify inhibitors of melanin biosynthesis via the quality control of tyrosinase. J Investig Dermatol 2007;127:751–61
  5. Tan X, Song YH, Park C, Lee KW, Kim JY, Kim DW, et al. Highly potent tyrosinase inhibitor, neorauflavane from Campylotropis hirtella and inhibitory mechanism with molecular docking. Bioorgan Med Chem 2016;24:153–9
  6. Xue CB, Luo WC, Ding Q, Liu SZ, Gao XX. Quantitative structure- activity relationship studies of mushroom tyrosinase inhibitors. J Comput Aid Mol Des 2008;22:299–309
  7. Taylor JS. The dark side of sunlight and melanoma. Science 2015;347:824
  8. Chen WF, Chakraborty C, Sung CS, Feng CW, Jean YH, Lin YY, et al. Neuroprotection by marine-derived compound, 11-dehydrosinulariolide, in an in vitro Parkinson’s model: a promising candidate for the treatment of Parkinson’s disease. N-S Arch Pharmacol 2012;385:265–75
  9. Goodspeed A, Heiser LM, Gray JW, Costello JC. Tumor-derived cell lines as molecular models of cancer pharmacogenomics. Mol Cancer Res 2016;14:3–13
  10. Pan TH, Li XQ, Jankovic J. The association between Parkinson’s disease and melanoma. Int J Cancer 2011;128:2251–60
  11. Serra PA, Esposito G, Enrico P, Mura MA, Migheli R, Delogu MR, et al. Manganese increases L-DOPA auto-oxidation in the stria- tum of the freely moving rat: potential implications to L-DOPA long-term therapy of Parkinson’s disease. Brit J Pharmacol 2000;130:937–45
  12. Ma D, Tu ZC, Wang H, Zhang L, He N, McClements DJ. Mechanism and kinetics of tyrosinase inhibition by glycolic acid: a study using conventional spectroscopy methods and hydrogen/deu- terium exchange coupling with mass spectrometry. Food Funct 2017;8:122–31
  13. Kim JM, Ko RK, Jung DS, Kim SS, Lee NH. Tyrosinase inhibitory constituents from the stems of Maackia fauriei. Phytother Res 2010;24:70–5. 14.